SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Momenta Pharmaceuticals Inc.
MNTA 52.480.0%Oct 2 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (2690)12/29/2010 4:43:19 PM
From: IRWIN JAMES FRANKEL   of 3027
 
That is the only one I recall.

I would add that it is characteristically different to tell an agency to make a decision than to tell it what decision to make or second-guess a decision made.

The latter is a higher hurdle.

One more thing. Much is being made about internal disagreement within the FDA as if that is somehow dispositive. I would suggest that many if not most difficult decisions will have internal agency dissenters. Ultimately someone has to make decisions and I consider it likely that the decisions will be better if made in the face of serious debate. Substituting a courts view for the agency will not happen often.

ij
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext